Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateSector Deep DivesUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Hospitals
  4. /Jupiter Life Line Hospitals Ltd
MomentumDeep Value

Jupiter Life Line Hospitals Ltd: Stock Analysis & Fundamentals

Updated this week

Jupiter Life Line Hospitals Ltd (Hospitals) — fundamental analysis, earnings data, and key metrics. PE: 45.5. ROE: 13.6%. This stock is not currently in the Nifty 500 momentum outperformers list.

Jupiter Life Line Hospitals Ltd Key Facts

What's Happening

💪Debt reduced 31% YoY — balance sheet strengthening
🏛️DII accumulation — stake up 3.5%

Key Numbers

Current Price
₹1,371
Dividend Yield
0.07%
Market Cap
9.0K Cr
Valuation
N/A

Other Top Hospitals Stocks Beating Nifty 500

Apollo Hospitals Enterprise Ltd
Average • 12w streak
+5.7%
Max Healthcare Institute Ltd
Average
+6.1%
Fortis Healthcare Ltd
Average
+7.4%
Narayana Hrudayalaya Ltd
Average
+7.4%
Aster DM Healthcare Ltd
Average • 12w streak
+10.3%
← Back to HospitalsDashboard

Frequently Asked Questions: Jupiter Life Line Hospitals Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Jupiter Life Line Hospitals Ltd's latest quarterly results?

Jupiter Life Line Hospitals Ltd's latest quarterly results (Mar 2026) show

  • PAT Growth YoY: +11.1%
  • Revenue Growth YoY: +15.1%
  • Operating Margin: 23.0%

What is Jupiter Life Line Hospitals Ltd's current PE ratio?

Jupiter Life Line Hospitals Ltd's current PE ratio is 45.5x.

  • Current PE: 45.5x
  • Market Cap: 9.0K Cr
  • Dividend Yield: 0.07%

What is Jupiter Life Line Hospitals Ltd's price-to-book ratio?

Jupiter Life Line Hospitals Ltd's price-to-book ratio is 5.8x.

  • Price-to-Book (P/B): 5.8x
  • Book Value per Share: ₹236
  • Current Price: ₹1371

Is Jupiter Life Line Hospitals Ltd a fundamentally strong company?

Jupiter Life Line Hospitals Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): 15.0%

Is Jupiter Life Line Hospitals Ltd debt free?

Jupiter Life Line Hospitals Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹584 Cr

What is Jupiter Life Line Hospitals Ltd's return on equity (ROE) and ROCE?

Jupiter Life Line Hospitals Ltd's return ratios over recent years

  • FY2024: ROCE 22.0%
  • FY2025: ROCE 18.0%
  • FY2026: ROCE 15.0%

Is Jupiter Life Line Hospitals Ltd's cash flow positive?

Jupiter Life Line Hospitals Ltd's operating cash flow is positive (FY2026).

  • Cash from Operations (CFO): ₹268 Cr
  • Free Cash Flow (FCF): ₹-174 Cr
  • CFO/PAT Ratio: 138% (strong cash conversion)

What is Jupiter Life Line Hospitals Ltd's dividend yield?

Jupiter Life Line Hospitals Ltd's current dividend yield is 0.07%.

  • Dividend Yield: 0.07%
  • Current Price: ₹1371

Who holds Jupiter Life Line Hospitals Ltd shares — promoters, FII, DII?

Jupiter Life Line Hospitals Ltd's shareholding pattern (Mar 2026)

  • Promoters: 40.9%
  • FII (Foreign): 8.5%
  • DII (Domestic): 17.0%
  • Public: 33.6%

Is promoter holding increasing or decreasing in Jupiter Life Line Hospitals Ltd?

Jupiter Life Line Hospitals Ltd's promoter holding has remained stable recently.

  • Current Promoter Holding: 40.9% (Mar 2026)
  • Previous Quarter: 40.9% (Dec 2025)
  • Change: 0.00% (stable)

Is Jupiter Life Line Hospitals Ltd a new momentum entry or an established outperformer?

Jupiter Life Line Hospitals Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Jupiter Life Line Hospitals Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Jupiter Life Line Hospitals Ltd may be worth studying

  • Cash flow is positive — CFO ₹268 Cr

What is the investment thesis for Jupiter Life Line Hospitals Ltd?

Jupiter Life Line Hospitals Ltd investment thesis summary:

What is the future outlook for Jupiter Life Line Hospitals Ltd?

Jupiter Life Line Hospitals Ltd's forward outlook based on current data signals

  • Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.